Kaia Health raises $75m for digital musculoskeletal disease therapyKaia Health has raised a further $75m to expand its AI-based treatment for Musculoskeletal (MSK) and chronic obstructive Share XKaia Health raises $75m for digital musculoskeletal disease therapyhttps://pharmaphorum.com/news/kaia-health-raises-75m-for-digital-musculoskeletal-disease-therapy/
Kaia Health gets $75m for digital solution to strains and pains of pandemic workplaceKaia Health has just announced a $75 million funding round for its technology, aimed at improving musculoskeletal (MSK) Share XKaia Health gets $75m for digital solution to strains and pains of pandemic workplacehttps://pharmaphorum.com/views-and-analysis/kaia-health-gets-75m-for-digital-solution-to-strains-and-pains-of-pandemic-workplace/
Hikma shares rally after US launch of Advair generic resumesShares in Hikma have rallied as it resumed the launch of its generic Advair Diskus in the US, Share XHikma shares rally after US launch of Advair generic resumeshttps://pharmaphorum.com/news/hikma-shares-rally-after-us-launch-of-advair-generic-resumes/
AstraZeneca breathes sigh of relief as court blocks US Symbicort genericA US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing Share XAstraZeneca breathes sigh of relief as court blocks US Symbicort generichttps://pharmaphorum.com/news/astrazeneca-breathes-sigh-of-relief-as-court-blocks-us-symbicort-generic/
Boost for Verona Pharma after trial win with inhaled COPD drugUK-based Verona Pharma has scored a new win with its chronic obstructive pulmonary disease (COPD) drug ensifenitrine, after Share XBoost for Verona Pharma after trial win with inhaled COPD drughttps://pharmaphorum.com/news/verona-pharma-scores-trial-win-with-inhaled-copd-drug/
Health Innovators: David Van Sickle on digital innovation in respiratory medicineIn the first episode of our Health Innovators series, Paul Tunnah speaks to David Van Sickle, CEO of Share XHealth Innovators: David Van Sickle on digital innovation in respiratory medicinehttps://pharmaphorum.com/views-and-analysis/health-innovators-david-van-sickle-on-digitalising-respiratory-medicine/
Verona Pharma to trial lung drug ensifentrine for COVID-19Verona Pharma is to develop its lung drug ensifentrine for patients with COVID-19, joining the legions of drug Share XVerona Pharma to trial lung drug ensifentrine for COVID-19https://pharmaphorum.com/news/verona-pharma-to-develop-lung-drug-for-covid-19/
AZ’s COPD triple therapy approved in the USAstraZeneca’s triple therapy for chronic obstructive pulmonary disease (COPD), Breztri Aerosphere (budesonide+glycopyrrolate+formoterol fumarate), has been approved in the Share XAZ’s COPD triple therapy approved in the UShttps://pharmaphorum.com/news/azs-copd-triple-therapy-approved-in-the-us/
Teva launches digital asthma and COPD rescue inhaler in USTeva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to Share XTeva launches digital asthma and COPD rescue inhaler in UShttps://pharmaphorum.com/news/fda-approves-tevas-digital-asthma-and-copd-rescue-inhaler/
